Solasto Corporation
Stock Price Chart
2026/08/13 UpdatedPrice Trend
2026/08/13 UpdatedPrice & Trading Details
2026/08/13 UpdatedPRICE
TRADING
Analyst Recommendations 2 analysts
Updated 2026/08/01Earnings Calendar
Updated 2026/08/01Recent Earnings
| Date | EPS Est. | EPS Actual | Surprise |
|---|---|---|---|
| 2022/02/07 | ¥12.20 | ¥11.38 | -6.7% |
Shareholder Composition
Updated 2026/08/01Dividend History 1Years Growth
Updated 2026/08/09| Year | Dividend | Change |
|---|---|---|
| 2025 | ¥21 | +5.0% |
| 2024 | ¥20 | 0.0% |
| 2023 | ¥20 | 0.0% |
| 2022 | ¥20 | 0.0% |
| 2021 | ¥20 | - |
Financial Performance
2026/08/09 UpdatedRevenue & Profit
Margins
Cash Flow
Financial Health
| 2023 | 2024 | 2025 | 2026 | |
|---|---|---|---|---|
| Income Statement | ||||
| Revenue | ¥131,088M | ¥135,139M | ¥137,435M | ¥141,144M |
| Gross Profit | ¥21,752M | ¥21,934M | ¥22,400M | ¥23,292M |
| Operating Income | ¥6,326M | ¥5,518M | ¥7,017M | ¥7,346M |
| Pretax Income | ¥5,690M | ¥4,429M | ¥6,741M | ¥6,614M |
| Net Income | ¥3,172M | ¥2,257M | ¥3,960M | ¥3,740M |
| EPS | ¥33.53 | ¥24.11 | ¥42.94 | ¥40.82 |
| Operating Margin | 4.83% | 4.08% | 5.11% | 5.20% |
| Balance Sheet | ||||
| Total Assets | ¥69,852M | ¥75,199M | ¥70,097M | ¥66,209M |
| Total Equity | ¥21,570M | ¥20,483M | ¥22,682M | ¥23,458M |
| Total Liabilities | ¥48,282M | ¥54,716M | ¥47,415M | ¥42,751M |
| Cash | ¥11,957M | ¥15,115M | ¥14,004M | ¥12,212M |
| Interest-bearing Debt | ¥25,886M | ¥28,515M | ¥23,076M | ¥18,116M |
| Equity Ratio | 30.88% | 27.24% | 32.36% | 35.43% |
| D/E Ratio | 1.20 | 1.39 | 1.02 | 0.77 |
| Cash Flow | ||||
| Operating CF | ¥9,012M | ¥7,858M | ¥5,877M | ¥6,818M |
| Investing CF | -¥2,171M | -¥2,762M | ¥347M | -¥548M |
| Financing CF | -¥5,211M | -¥1,837M | -¥7,335M | -¥8,061M |
| Free CF | ¥7,688M | ¥6,282M | ¥5,055M | ¥6,025M |
| Efficiency | ||||
| ROE | 14.71% | 11.02% | 17.46% | 15.94% |
| ROA | 4.54% | 3.00% | 5.65% | 5.65% |
Latest IR Information
-
Notice Regarding Delisting of Our Shares
This is a notice regarding the delisting of shares. Specific figures are not disclosed. While the body mentions the reasons, date, and procedures for delisting, those details are not provided here.
Read more -
Notice Regarding Resolution for Approval of Share Consolidation, Abolition of the Unit Share, and Partial Amendment of Articles of Incorporation
Approval of share consolidation and partial amendment to the Articles of Incorporation decided at an extraordinary general meeting. Consolidation ratio set at 1 share per 2,120,340 shares; delisting date planned for August 6, 2026. Details on fractional share handling, sale...
Read more -
【Solasto】Change of Controlling Shareholder and Management Policy | June 2026
Following the announcement dated May 12, 2026, MP-2605 Corporation has become the parent company of the Company, and procedures for becoming a wholly owned subsidiary are underway. The change in controlling shareholder and management structure are key points.
Read more -
Resolution to Cancel Treasury Stock | August 7, 2026
Solasto Corporation has scheduled the cancellation of treasury stock on August 7, 2026, contingent upon approval of a share consolidation proposal at the extraordinary general meeting of shareholders in July 2026.
Read more -
[Solasto Corporation] Announcing Share Consolidation and Delisting | July 2026
Solasto Corporation is implementing a share consolidation and plans to delist from the Tokyo Stock Exchange on August 6, 2026. The announcement also includes details on treasury stock cancellation and other capital policy changes.
Read more -
【Solasto】Notice of Director Appointment | May 27, 2026
On May 27, 2026, Solasto announced the appointment of new directors. Several new executives have been appointed, with the selection reason involving leveraging diverse expertise and experience.
Read more
Latest News (5 items)
-
Average Analyst Rating: none
Average Target Price: ¥690
Rating Score: 2.50 (Based on 2 analysts)
※1=Strong Buy, 5=Strong Sell
Company Information
About
Solasto Corporation provides medical outsourcing services to medical institutions in Japan. It operates through the Medical Business, Nursing Care Business, Children's Business, and Others segments. The Medical Business segment offers medical administration, medical affairs, and hospital management support services, as well as various surveys and analyses in the fields of medical administration and hospital management, document preparation, lectures and training, and educational courses on medical administration services. Its Nursing Care Business segment provides nursing care services, including nursing homes, residential nursing homes, and serviced housing for the elderly, as well as day care and home help services. The Children's Business segment offers childcare services, such as licensed, certified, and small-scale childcare centers, as well as childcare centers for recovering children. Its Others segment operates its smart hospital business that provides remote medical fee billing services to medical institutions. Solasto Corporation was formerly known as N.I.C Corporation. The company was founded in 1965 and is headquartered in Tokyo, Japan. As of May 11, 2026, Solasto Corporation operates as a subsidiary of MP-2605 Co., Ltd.
